{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:04:43Z","timestamp":1761843883896,"version":"3.37.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.transproceed.2009.02.019","type":"journal-article","created":{"date-parts":[[2009,4,18]],"date-time":"2009-04-18T08:38:34Z","timestamp":1240043914000},"page":"1021-1024","source":"Crossref","is-referenced-by-count":23,"title":["Severe Rhabdomyolysis and Acute Renal Failure Secondary to Concomitant Use of Simvastatin With Rapamycin Plus Tacrolimus in Liver Transplant Patient"],"prefix":"10.1016","volume":"41","author":[{"given":"C.","family":"Dopazo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bilbao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sapisochin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Caralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Charco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2009.02.019_bib1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/01.sla.0000164077.77912.98","article-title":"Analysis of long term outcomes of 3,200 liver transplantations over two decades","volume":"241","author":"Busuttil","year":"2005","journal-title":"Ann Surg"},{"issue":"11 suppl","key":"10.1016\/j.transproceed.2009.02.019_bib2","first-page":"SS51","article-title":"Impact and management of hyperlipidemia post-transplantation","volume":"70","author":"Fellstrom","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.02.019_bib3","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1053\/jlts.2001.29167","article-title":"Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity","volume":"7","author":"Reuben","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2009.02.019_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-0012.1996.tb00431.x","article-title":"Metabolic problems in recipients of liver transplants","volume":"10","author":"Jindal","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2009.02.019_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2165\/00002018-200124100-00004","article-title":"Calcineurin inhibitors and post-transplant hyperlipidaemias","volume":"24","author":"Moore","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.transproceed.2009.02.019_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2009.02.019_bib7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1399-0012.2004.00253.x","article-title":"Dyslipidemia during sirolimus therapy in patients after liver transplantation","volume":"18","author":"Kniepeiss","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2009.02.019_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","article-title":"Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors","volume":"41","author":"Williams","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.transproceed.2009.02.019_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/01.CIR.0000131519.15067.1f","article-title":"Safety of statins: focus on clinical pharmacokinetics and drug interactions","volume":"109","author":"Bellosta","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2009.02.019_bib10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ajhp\/60.7.698","article-title":"High dose simvastatin and rhabdomyolysis","volume":"60","author":"Wratchford","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.transproceed.2009.02.019_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.TP.0000100685.70064.90","article-title":"Is there a disparity between risk and incidence of cardiovascular disease after liver transplant?","volume":"77","author":"Neal","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.02.019_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00007890-200203270-00012","article-title":"Cardiovascular morbidity and mortality after orthotopic liver transplantation","volume":"73","author":"Johnston","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.02.019_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/152216280100400405","article-title":"Management of hyperlipidemia in the stable solid organ transplant recipient","volume":"4","author":"Abtahi","year":"2001","journal-title":"Graft"},{"key":"10.1016\/j.transproceed.2009.02.019_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00002018-200022060-00003","article-title":"HMG-CoA reductase inhibitors and myotoxicity","volume":"22","author":"Ucar","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.transproceed.2009.02.019_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00002018-199819050-00003","article-title":"Drug interactions of lipid-altering drugs","volume":"19","author":"Bays","year":"1998","journal-title":"Drug Saf"},{"key":"10.1016\/j.transproceed.2009.02.019_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003495-200363040-00003","article-title":"Interactions between cyclosporine and lipid-lowering drugs","volume":"63","author":"Asberg","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2009.02.019_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3122\/jabfm.2007.04.060187","article-title":"Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir","volume":"20","author":"Schmidt","year":"2007","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.transproceed.2009.02.019_bib18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/pds.1287","article-title":"Risk factors for statin associated rhabdomyolysis","volume":"16","author":"Schech","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.transproceed.2009.02.019_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1524-6175.2005.05278.x","article-title":"Fibrates in combination with statins in the management of dyslipidemia","volume":"8","author":"Jacobson","year":"2006","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.transproceed.2009.02.019_bib20","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2009.02.019_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-0012.2007.00780.x","article-title":"Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients","volume":"22","author":"Martin","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2009.02.019_bib22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1345\/aph.10315","article-title":"Statin-fibrate combination therapy","volume":"35","author":"Shek","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.transproceed.2009.02.019_bib23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.transproceed.2004.03.019","article-title":"Severe rhabdomyolysis and acute renal failure in a kidney transplant patient treated with tacrolimus and chimaeric CD25 monoclonal antibody","volume":"36","author":"Fontana","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2009.02.019_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1053-2498(01)00369-2","article-title":"Safety and efficacy of atorvastatin in heart transplant recipients","volume":"21","author":"Patel","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2009.02.019_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1023\/A:1015052312866","article-title":"The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study","volume":"32","author":"Turk","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.transproceed.2009.02.019_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1053-2498(00)00077-2","article-title":"Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation","volume":"19","author":"Keogh","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2009.02.019_bib27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1053-2498(00)00128-5","article-title":"Role of statin in the management of dyslipidemia after cardiac transplant: randomized, controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin","volume":"19","author":"Magnani","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2009.02.019_bib28","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0041-1345(00)02382-4","article-title":"Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: a double blind, randomized, placebo-controlled study","volume":"33","author":"Santos","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2009.02.019_bib29","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1681\/ASN.2007020158","article-title":"Acute renal failure and myalgia in a transplant recipient","volume":"18","author":"Najafian","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2009.02.019_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0168-8278(01)00044-7","article-title":"Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized crossover trial","volume":"35","author":"Zachoval","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2009.02.019_bib31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1399-6576.2005.00577.x","article-title":"Prognostic value, kinetics and effect of CVVHDF on serum of myoglobin and creatine kinase in critically ill patients with rhabdomyolysis","volume":"49","author":"Mikkelsen","year":"2005","journal-title":"Acta Anaesthesiol Scand"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T01:54:46Z","timestamp":1739066086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134509001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0041134509001560"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2009.02.019","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}